Latest Insider Transactions at La Jolla Pharmaceutical CO (LJPC)
This section provides a real-time view of insider transactions for La Jolla Pharmaceutical CO (LJPC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LA JOLLA PHARMACEUTICAL CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LA JOLLA PHARMACEUTICAL CO's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 22
2022
|
David A Ramsay Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
100,000
-100.0%
|
$600,000
$6.23 P/Share
|
Aug 22
2022
|
Tang Kevin C Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
19,215,868
-100.0%
|
$115,295,208
$6.23 P/Share
|
Aug 22
2022
|
Laura L. Johnson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
500
-100.0%
|
$3,000
$6.23 P/Share
|
Aug 22
2022
|
Craig A Johnson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,000
-100.0%
|
$72,000
$6.23 P/Share
|
Aug 22
2022
|
Michael S Hearne Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
9,607,934
-100.0%
|
$57,647,604
$6.23 P/Share
|
Aug 22
2022
|
Michael S Hearne Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,186
-100.0%
|
$61,116
$6.23 P/Share
|
Aug 22
2022
|
Larry G. Edwards Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,969
-100.0%
|
$71,814
$6.23 P/Share
|
Jul 08
2022
|
Craig A Johnson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$36,000
$3.93 P/Share
|
Jun 30
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
236
+2.26%
|
$472
$2.71 P/Share
|
Jun 15
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
236
+2.32%
|
$472
$2.72 P/Share
|
May 31
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
189
+1.91%
|
$567
$3.41 P/Share
|
May 13
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
188
+1.94%
|
$564
$3.41 P/Share
|
Apr 29
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
185
+1.94%
|
$555
$3.47 P/Share
|
Apr 14
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
173
+1.86%
|
$519
$3.71 P/Share
|
Apr 14
2022
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
296
+2.41%
|
$888
$3.71 P/Share
|
Mar 31
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
177
+1.93%
|
$531
$3.63 P/Share
|
Mar 31
2022
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
334
+2.78%
|
$1,002
$3.63 P/Share
|
Mar 15
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
190
+2.11%
|
$570
$3.37 P/Share
|
Mar 15
2022
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
361
+3.09%
|
$1,083
$3.37 P/Share
|
Feb 28
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
185
+2.1%
|
$555
$3.48 P/Share
|
Feb 28
2022
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350
+3.09%
|
$1,050
$3.48 P/Share
|
Feb 15
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
169
+1.97%
|
$507
$3.79 P/Share
|
Feb 15
2022
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
320
+2.92%
|
$960
$3.79 P/Share
|
Jan 31
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,675
+16.86%
|
$5,025
$3.94 P/Share
|
Jan 31
2022
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,170
+28.8%
|
$12,510
$3.94 P/Share
|
Jan 14
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
148
+2.2%
|
$592
$4.18 P/Share
|
Jan 14
2022
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
273
+4.26%
|
$1,092
$4.18 P/Share
|
Dec 30
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
157
+2.38%
|
$471
$3.92 P/Share
|
Dec 30
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
233
+3.82%
|
$699
$3.92 P/Share
|
Dec 15
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
173
+2.68%
|
$519
$3.58 P/Share
|
Dec 15
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
320
+5.38%
|
$960
$3.58 P/Share
|
Dec 06
2021
|
David A Ramsay Director |
BUY
Open market or private purchase
|
Direct |
10,000
+1.46%
|
$30,000
$3.81 P/Share
|
Dec 03
2021
|
David A Ramsay Director |
BUY
Open market or private purchase
|
Direct |
4,399
+1.22%
|
$13,197
$3.66 P/Share
|
Dec 02
2021
|
David A Ramsay Director |
BUY
Open market or private purchase
|
Direct |
10,101
+1.74%
|
$30,303
$3.74 P/Share
|
Dec 01
2021
|
Tang Kevin C Director |
SELL
Open market or private sale
|
Indirect |
177,545
-0.91%
|
$532,635
$3.71 P/Share
|
Nov 30
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
186
+2.96%
|
$558
$3.31 P/Share
|
Nov 30
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
346
+6.12%
|
$1,038
$3.31 P/Share
|
Nov 30
2021
|
Tang Kevin C Director |
SELL
Open market or private sale
|
Indirect |
70,342
-0.36%
|
$211,026
$3.95 P/Share
|
Nov 29
2021
|
Tang Kevin C Director |
SELL
Open market or private sale
|
Indirect |
193,403
-1.92%
|
$773,612
$4.1 P/Share
|
Nov 17
2021
|
David A Ramsay Director |
BUY
Open market or private purchase
|
Direct |
7,500
+9.04%
|
$30,000
$4.23 P/Share
|
Nov 15
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
181
+2.97%
|
$543
$3.41 P/Share
|
Nov 15
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
336
+6.34%
|
$1,008
$3.41 P/Share
|
Oct 29
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
181
+3.06%
|
$543
$3.42 P/Share
|
Oct 29
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
335
+6.75%
|
$1,005
$3.42 P/Share
|
Oct 15
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
183
+3.19%
|
$549
$3.37 P/Share
|
Oct 15
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
341
+7.36%
|
$1,023
$3.37 P/Share
|
Sep 30
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
182
+3.28%
|
$546
$3.39 P/Share
|
Sep 30
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
338
+7.88%
|
$1,014
$3.39 P/Share
|
Sep 15
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
546
+9.52%
|
$1,638
$3.39 P/Share
|
Sep 15
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
338
+8.55%
|
$1,014
$3.39 P/Share
|